Amlodipine Ameliorates Up-Regulation of ET-۱ in Left Ventricle of Hypercholesterolemia Rabbits

Publish Year: 1389
نوع سند: مقاله ژورنالی
زبان: English
View: 160

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-13-4_011

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s) In addition to antihypertensive effects, amlodipine may exhibit cardiovascular protective effects in heart tissue. The aim of this study was to evaluate the effects of amlodipine and/or high cholesterol diet on blood, heart tissue concentration and mRNA expression of endothelin-۱ (ET-۱) in male New Zealand white rabbits. Materials and Methods A total of ۴۰ male New Zealand rabbits were divided into four groups: the normal control group, normal group receiving amlodipine, high-cholesterol diet group and high-cholesterol diet with amlodipine group. After ۸ weeks, all the animals anesthetized and blood or tissues samples were collected. Results After ۸ weeks of a high cholesterol diet, the group with such a diet had a significantly higher ratio of left ventricle (LV) weight to body weight than the control group (P= ۰.۰۰۰۱). After treatment with amlodipine for ۸ weeks, ET-۱ level was reduced considerably in comparison with the control (P= ۰.۰۱) and high- cholesterol diet groupes (P= ۰.۰۱). Amlodipine consumption caused significant reduction (P= ۰.۰۱) in the level of ET-۱ in heart tissues of high-cholesterol diet group but it had no remarkable effect on the reduction of heart tissue ET-۱ in amlodipine group compared with the control group. Conclusion The present study demonstrates that ventricular prepro-ET-۱ mRNA quantitatively increases in the high- cholesterol diet rabbits which results in development of ventricular hypertrophy. It seems that the treatment with amlodipine retards the progression of LV hypertrophy through attenuation of ET-۱ levels independent of lipid changes.

Authors

Iraj Salehi

Department of Physiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Safar Farajnia

Biotechnology Research Center & Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mustafa Mohammadi

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Masoud Sabouri Ghannad

Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.James PT, Rigby N, Leach R. International obesity task Force. ...
  • ۲.Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical ...
  • ۳.Hubert HB, Feinleib M, McNamara PM, Casteelii WP. Obesity as ...
  • ۴.Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, ...
  • ۵.Sadoshima J, Izumo S. The cellular andmolecular response of cardiac ...
  • ۶.Castelli WP, Anderson K. A population at risk: prevalence of ...
  • ۷.Bohn F, Johansson B, Hedin U, Alving K, Pernow J. ...
  • ۸.Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, ...
  • ۹.Haak T, Marz W, Jungmann E, Hausser S, Siekmeier R, ...
  • ۱۰.Yue TL, Gu JL, Wang C, Reith AD, Lee JC, ...
  • ۱۱.Davenport AP,Maguire JJ. Of mice and men: advances in endothelin ...
  • ۱۲.Waters D, Lesperance J, Francetich M, Causey D, Theroux P, ...
  • ۱۳.Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, ...
  • ۱۴.Jukema JW, Zwinderman AH, van Boven AJ, Reiber JH, Van ...
  • ۱۵.Catapano AL. Calcium antagonists and atherosclerosis. Experimental evidence. Eur Heart ...
  • ۱۶.Bellosta S, Bernini F. Lipophilic Calcium Antagonists in Antiatherosclerotic Therapy. ...
  • ۱۷.Mitani H, Takimoto M, Bandoh T, Kimura M. Increases of ...
  • ۱۸.Sugden PH. Signaling pathways activated by vasoactive peptides in the ...
  • ۱۹.Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, ...
  • ۲۰.Ishiye M, Umemura K, Uematsu T, Nakashima M. Angiotensin AT۱ ...
  • ۲۱.Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, ...
  • ۲۲.Hu CT, Chang HR, Hsu YH, Liu CJ, Chen HI. ...
  • ۲۳.Castro GJ, Bhatnagar A. Effect of extracellular ions and modulators ...
  • ۲۴.Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, ...
  • ۲۵.Lee TM, Chou TF, Tsai CH. Association of pravastatin and ...
  • نمایش کامل مراجع